Luvadaxistat clinical trials
Also written TAK-831 and NBI-1065844.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How each study uses luvadaxistat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2018 (4)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 0
Studies
Open first, then newest update. How each study uses luvadaxistat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaTerminatedPhase 2Neurocrine BiosciencesNCT05182476Written as LuvadaxistatHow we know
- A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of SchizophreniaCompletedPhase 2Neurocrine BiosciencesNCT03382639Written as LuvadaxistatHow we know
- A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With SchizophreniaCompletedPhase 2Neurocrine BiosciencesNCT03359785Written as LuvadaxistatHow we know
- A Study to Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy ParticipantsCompletedPhase 1Neurocrine BiosciencesNCT04234672Written as TAK-831 Oral TabletHow we know
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy ParticipantsCompletedPhase 1Neurocrine BiosciencesNCT03224325Written as TAK-831 Tablet T2How we know
- A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy ParticipantsCompletedPhase 1Neurocrine BiosciencesNCT03706469Written as TAK-831 T2How we know
- Phase 1 Study of TAK-831 in Healthy Adult Asian SubjectsCompletedPhase 1Neurocrine BiosciencesNCT03687684Written as TAK-831How we know
- Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich AtaxiaCompletedPhase 2Neurocrine BiosciencesNCT03214588Written as TAK-831How we know
- Study to Determine D-amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-dose Oral AdministrationCompletedPhase 1Neurocrine BiosciencesNCT02716987Written as TAK-831How we know
- A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet FormulationCompletedPhase 1Neurocrine BiosciencesNCT03101293Written as TAK-831How we know
- A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy ParticipantsTerminatedPhase 1Neurocrine BiosciencesNCT02566759Written as TAK-831 Oral SuspensionHow we know
Codes
What other systems call luvadaxistat · ClinicalTrials.gg INT015413
- UNII (FDA) 76IC00YRVRLUVADAXISTATConfirmed FDA, Wikidata
- Wikidata Q106651232luvadaxistatConfirmed FDA, Wikidata
- NCI Thesaurus C175119LuvadaxistatOne source FDA
- DrugBank DB16067One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 76IC00YRVR | LUVADAXISTAT | Confirmed FDA, Wikidata |
| Wikidata | Q106651232 | luvadaxistat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C175119 | Luvadaxistat | One source FDA |
| DrugBank | DB16067 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.